Determinants of treatment decisions of patients with pancreatic cancer in shared decision-making: A qualitative study
Leonieke Daanen1 2* , Mirelle Hanskamp-Sebregts2, Inger Abma3, Philip van der Wees3, Kees van Laarhoven4, Anneke de Jong5, Marion van der Kolk4
* Corresponding author: Leonieke.Daanen@radboudumc.nl, + 31 24 36 17835
1 Radboud University Medical Center, Emergency Department, internal postal code 760, PO Box 9101, 6500 HB Nijmegen, the Netherlands
2 Radboud University Medical Center, Institute of Quality Assurance and Patient Safety, internal postal code 348, PO Box 9101, 6500 HB Nijmegen, the Netherlands
3 Radboud Institute of Health Sciences, IQ healthcare, internal postal code 114, PO Box 9101, 6500 HB Nijmegen, the Netherlands
4 Radboud University Medical Center, Department of Surgery, internal postal code 618, PO Box 9101, 6500 HB Nijmegen, the Netherlands
5 University of Applied Sciences, Master of Care Trajectory Design, Heidelberglaan 8,
3584 CS Utrecht, the Netherlands
Abstract Word Count: 298 words
Manuscript Word Count: 3.128 words (excluding title page, abstract, references and tables)
Abstract
Rationale and aims
Shared decision-making is an approach whereby clinicians and patients make decisions together using the best available evidence. The most common cancers studied in relation to shared decision-making are breast and prostate. However, little is known about shared decision-making in patients with pancreatic cancer. We aimed to identify the determinants that influence pancreatic cancer patients in making treatment decisions during shared decision-making.